Anthony Ho

This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles free of charge to researchers worldwide.

Research Profile (preview)

Procedures

Disorders

Anatomy

Concepts & Ideas

Chemicals & Drugs

Sign-in to see full Profile

Sign-in to see all Coauthors

Publications

TOP 3
Seckinger A; Meissner T; Moreaux J; Goldschmidt H; Fuhler G M; Benner A; Hundemer M; Rème T; Shaughnessy J D; Barlogie B; Bertsch U; Hillengass J; Ho A D; Pantesco V; Jauch A; De Vos J; Rossi J F; Möhler T; Klein B; Hose D
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.
Schönland S O; Moos M; Bochtler T; Ho A D; Hegenbart U
[Systemic light chain amyloidosis - molecular basis and clinical perspectives]
Löffler H; Kosely F; Ho A D; Krämer A
[Blastic plasmacytoid dendritic cell neoplasm - a rare differential diagnosis of neoplastic skin infiltrations associated with systemic symptoms]

Sign-in to see all Publications

Sign in free and see...

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the visualized research activity
of experts around the globe

Sign-in to see more

Geonetwork of Anthony Ho (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

Sign-in to see more

All Publications

2009: Seckinger A; Meissner T; Moreaux J; Goldschmidt H; Fuhler G M; Benner A; Hundemer M; Rème T; Shaughnessy J D; Barlogie B; Bertsch U; Hillengass J; Ho A D; Pantesco V; Jauch A; De Vos J; Rossi J F; Möhler T; Klein B; Hose D
Bone morphogenic protein 6: a member of a novel class of prognostic factors expressed by normal and malignant plasma cells inhibiting proliferation and angiogenesis.
Oncogene 2009;28(44):3866-79.
2009: Schönland S O; Moos M; Bochtler T; Ho A D; Hegenbart U
[Systemic light chain amyloidosis - molecular basis and clinical perspectives]
Deutsche medizinische Wochenschrift (1946) 2009;134(39):1949-52.
2009: Löffler H; Kosely F; Ho A D; Krämer A
[Blastic plasmacytoid dendritic cell neoplasm - a rare differential diagnosis of neoplastic skin infiltrations associated with systemic symptoms]
Deutsche medizinische Wochenschrift (1946) 2009;134(39):1927-30.
2009: Kasper B; Schmitt T; Wuchter P; Ho A D; Egerer G
[Positron emission tomography as a tool for early prediction of therapy outcome in soft tissue sarcoma]
Deutsche medizinische Wochenschrift (1946) 2009;134(39):1922-6.
2009: Kornacker M; Stumm J; Pott C; Dietrich S; Süssmilch S; Hensel M; Nickelsen M; Witzens-Harig M; Kneba M; Schmitz N; Ho A D; Dreger P
Characteristics of relapse after autologous stem-cell transplantation for follicular lymphoma: a long-term follow-up.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(4):722-8.
2009: Witzens-Harig Mathias; Reiz Monika; Heiss Christiane; Benner Axel; Hensel Manfred; Neben Kai; Dreger Peter; Kraemer Alwin; Ho Anthony D
Quality of life during maintenance therapy with the anti-CD20 antibody rituximab in patients with B cell non-Hodgkin's lymphoma: results of a prospective randomized controlled trial.
Annals of hematology 2009;88(1):51-7.
2009: Kornacker M; Kornacker B; Schmitt C; Leo E; Ho A D; Hensel M
Commercial LightCycler-based quantitative real-time PCR compared to nested PCR for monitoring of Bcl-2/IgH rearrangement in patients with follicular lymphoma.
Annals of hematology 2009;88(1):43-50.
2008: Tretter Theresa; Venigalla Ram K C; Eckstein Volker; Saffrich Rainer; Sertel Serkan; Ho Anthony D; Lorenz Hanns-Martin
Induction of CD4+ T-cell anergy and apoptosis by activated human B cells.
Blood 2008;112(12):4555-64.
2008: Hillengass J; Ho A D; Goldschmidt H; Waldherr R; Moehler T M
Clinical evidence for immunomodulation induced by high-dose melphalan and autologous blood stem cell transplantation as cause for complete clinical remission of multiple myeloma-associated cryoglobulin-vasculitis.
International journal of hematology 2008;88(4):454-6.
2008: Perz J B; Ritgen M; Moos M; Ho A D; Kneba M; Dreger P
Occurrence of donor-derived CLL 8 years after sibling donor SCT for CML.
Bone marrow transplantation 2008;42(10):687-8.
2008: Lannert H; Able T; Becker S; Sommer M; Braun M; Stadtherr P; Ho A D
Optimizing BM harvesting from normal adult donors.
Bone marrow transplantation 2008;42(7):443-7.
2008: Steinhoff G; Tiedemann G; Thalheimer M; Ho A D
[From basic research to the clinic. Regulations for preclinical and clinical studies with stem cells]
Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz 2008;51(9):973-9.
2008: Beckermann B M; Kallifatidis G; Groth A; Frommhold D; Apel A; Mattern J; Salnikov A V; Moldenhauer G; Wagner W; Diehlmann A; Saffrich R; Schubert M; Ho A D; Giese N; Büchler M W; Friess H; Büchler P; Herr I
VEGF expression by mesenchymal stem cells contributes to angiogenesis in pancreatic carcinoma.
British journal of cancer 2008;99(4):622-31.
2008: Belle Sebastian; Han Fang; Condomines Maud; Christensen Olaf; Witzens-Harig Mathias; Kasper Bernd; Kleist Christian; Terness Peter; Moos Marion; Cremer Friedrich; Hose Dirk; Ho Anthony D; Goldschmidt Hartmut; Klein Bernard; Hundemer Michael
Identification of HLA-A2 restricted T-cell epitopes within the conserved region of the immunoglobulin G heavy-chain in patients with multiple myeloma.
European journal of haematology 2008;81(1):26-35.
2008: Schonland Stefan O; Hansmann Jochen; Mechtersheimer Gunnhild; Goldschmidt Hartmut; Ho Anthony D; Hegenbart Ute
Bone involvement in patients with systemic AL amyloidosis mimics lytic myeloma bone disease.
Haematologica 2008;93(6):955-6.
2008: Lorenz Hanns-Martin; Dalpke Alexander H; Deboben Axel; Ho Anthony D; Greiner Axel; Jung Martin; Fiehn Christoph
Mycobacterium kansasii tenosynovitis in a rheumatoid arthritis patient with long-term therapeutic immunosuppression.
Arthritis and rheumatism 2008;59(6):900-3.
2008: Hillengass Jens; Zechmann Christian M; Nadler Andreas; Hose Dirk; Cremer Friedrich W; Jauch Anna; Heiss Christiane; Benner Axel; Ho Anthony D; Bartram Claus R; Kauczor Hans-Ulrich; Delorme Stefan; Goldschmidt Hartmut; Moehler Thomas M
Gain of 1q21 and distinct adverse cytogenetic abnormalities correlate with increased microcirculation in multiple myeloma.
International journal of cancer. Journal international du cancer 2008;122(12):2871-5.
2008: Pfreundschuh Michael; Ho Anthony D; Cavallin-Stahl Eva; Wolf Max; Pettengell Ruth; Vasova Ingrid; Belch Andrew; Walewski Jan; Zinzani Pier-Luigi; Mingrone Walter; Kvaloy Stein; Shpilberg Ofer; Jaeger Ulrich; Hansen Mads; Corrado Claudia; Scheliga Adriana; Loeffler Markus; Kuhnt Evelyn;
Prognostic significance of maximum tumour (bulk) diameter in young patients with good-prognosis diffuse large-B-cell lymphoma treated with CHOP-like chemotherapy with or without rituximab: an exploratory analysis of the MabThera International Trial Group (MInT) study.
The lancet oncology 2008;9(5):435-44.
2008: Bochtler Tilmann; Hegenbart Ute; Cremer Friedrich W; Heiss Christiane; Benner Axel; Hose Dirk; Moos Marion; Bila Jelena; Bartram Claus R; Ho Anthony D; Goldschmidt Hartmut; Jauch Anna; Schonland Stefan O
Evaluation of the cytogenetic aberration pattern in amyloid light chain amyloidosis as compared with monoclonal gammopathy of undetermined significance reveals common pathways of karyotypic instability.
Blood 2008;111(9):4700-5.
2008: Perz Jolanta B; Ho Anthony D
Histamine dihydrochloride for the treatment of acute myeloid leukemia, malignant melanoma and renal cell carcinoma.
Future oncology (London, England) 2008;4(2):169-77.
2008: Frank Christian; Hundemer Michael; Ho Anthony D; Goldschmidt Hartmut; Witzens-Harig Mathias
Cellular immune responses against the cancer-testis antigen SPAN-XB in healthy donors and patients with multiple myeloma.
Leukemia & lymphoma 2008;49(4):779-85.
2008: Schmitt S; Mailaender V; Egerer G; Leo A; Becker S; Reinhardt P; Wiesneth M; Schrezenmeier H; Ho A D; Goldschmidt H; Moehler T M
Successful autologous peripheral blood stem cell transplantation in a Jehovah's Witness with multiple myeloma: review of literature and recommendations for high-dose chemotherapy without support of allogeneic blood products.
International journal of hematology 2008;87(3):289-97.
2008: Kallifatidis G; Beckermann B M; Groth A; Schubert M; Apel A; Khamidjanov A; Ryschich E; Wenger T; Wagner W; Diehlmann A; Saffrich R; Krause U; Eckstein V; Mattern J; Chai M; Schütz G; Ho A D; Gebhard M M; Büchler M W; Friess H; Büchler P; Herr I
Improved lentiviral transduction of human mesenchymal stem cells for therapeutic intervention in pancreatic cancer.
Cancer gene therapy 2008;15(4):231-40.
2008: Kasper Bernd; Dietrich Sascha; Dimitrakopoulou-Strauss Antonia; Strauss Ludwig G; Haberkorn Uwe; Ho Anthony D; Egerer Gerlinde
Early prediction of therapy outcome in patients with high-risk soft tissue sarcoma using positron emission tomography.
Onkologie 2008;31(3):107-12.
2008: Bochtler Tilmann; Hegenbart Ute; Heiss Christiane; Benner Axel; Cremer Friedrich; Volkmann Martin; Ludwig Jochen; Perz Jolanta B; Ho Anthony D; Goldschmidt Hartmut; Schonland Stefan O
Evaluation of the serum-free light chain test in untreated patients with AL amyloidosis.
Haematologica 2008;93(3):459-62.
2008: Jonas Jost B; Witzens-Harig Mathias; Arseniev Lubomir; Ho Anthony D
Intravitreal autologous bone marrow-derived mononuclear cell transplantation: a feasibility report.
Acta ophthalmologica 2008;86(2):225-6.
2008: Lutz Matthias; Rosenberg Mark; Kiessling Fabian; Eckstein Volker; Heger Thomas; Krebs Jutta; Ho Anthony D; Katus Hugo A; Frey Norbert
Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit + bone marrow-derived stem cells.
Cardiovascular research 2008;77(1):143-50.
2008: Schiller M; Bekeredjian-Ding I; Heyder P; Blank N; Ho A D; Lorenz H-M
Autoantigens are translocated into small apoptotic bodies during early stages of apoptosis.
Cell death and differentiation 2008;15(1):183-91.
2008: Horn P; Bork S; Diehlmann A; Walenda T; Eckstein V; Ho A D; Wagner W
Isolation of human mesenchymal stromal cells is more efficient by red blood cell lysis.
Cytotherapy 2008;10(7):676-85.
2008: Ho A D; Wagner W; Franke W
Heterogeneity of mesenchymal stromal cell preparations.
Cytotherapy 2008;10(4):320-30.
2008: Wagner Wolfgang; Horn Patrick; Castoldi Mirco; Diehlmann Anke; Bork Simone; Saffrich Rainer; Benes Vladimir; Blake Jonathon; Pfister Stefan; Eckstein Volker; Ho Anthony D
Replicative senescence of mesenchymal stem cells: a continuous and organized process.
PloS one 2008;3(5):e2213.
2008: Wagner Wolfgang; Wein Frederik; Roderburg Christoph; Saffrich Rainer; Diehlmann Anke; Eckstein Volker; Ho Anthony D
Adhesion of human hematopoietic progenitor cells to mesenchymal stromal cells involves CD44.
Cells, tissues, organs 2008;188(1-2):160-9.
2007: Wagner Wolfgang; Ho Anthony D
Mesenchymal stem cell preparations--comparing apples and oranges.
Stem cell reviews 2007;3(4):239-48.
2007: Hundemer M; Klein U; Hose D; Raab M-S; Cremer F W; Jauch A; Benner A; Heiss C; Moos M; Ho A D; Goldschmidt H
Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14).
Bone marrow transplantation 2007;40(11):1033-7.
2007: Luft Thomas; Conzelmann Michael; Benner Axel; Rieger Michael; Hess Michael; Strohhaecker Ulrich; Görner Martin; Hegenbart Ute; Ho Anthony D; Dreger Peter
Serum cytokeratin-18 fragments as quantitative markers of epithelial apoptosis in liver and intestinal graft-versus-host disease.
Blood 2007;110(13):4535-42.
2007: Gottschling Sandra; Eckstein Volker; Saffrich Rainer; Jonás Alexandr; Uhrig Markus; Krause Ulf; Seckinger Anja; Miesala Katrin; Horsch Kerstin; Straub Beate K; Ho Anthony D
Primitive and committed human hematopoietic progenitor cells interact with primary murine neural cells and are induced to undergo self-renewing cell divisions.
Experimental hematology 2007;35(12):1858-71.
2007: Witzens-Harig Mathias; Waldherr Rüdiger; Beimler Joerg; Zeier Martin; Hansmann Jochen; Ho Anthony D; Goldschmidt Hartmut; Moehler Thomas
Long-term remission of paraprotein-induced immunotactoid glomerulopathy after high-dose therapy and autologous blood stem cell transplantation.
Annals of hematology 2007;86(12):927-30.
2007: Tita-Nwa Freddy; Moldenhauer Gerhard; Herbst Markus; Kleist Christian; Ho Anthony D; Kornacker Martin
Cytokine-induced killer cells targeted by the novel bispecific antibody CD19xCD5 (HD37xT5.16) efficiently lyse B-lymphoma cells.
Cancer immunology, immunotherapy : CII 2007;56(12):1911-20.
2007: Löffler Harald; Bochtler Tilmann; Fritz Britta; Tews Björn; Ho Anthony D; Lukas Jiri; Bartek Jiri; Krämer Alwin
DNA damage-induced accumulation of centrosomal Chk1 contributes to its checkpoint function.
Cell cycle (Georgetown, Tex.) 2007;6(20):2541-8.
2007: Schweizer Christof; Reu Frederic J; Ho Anthony D; Hensel Manfred
Low rate of long-lasting remissions after successful treatment of immune thrombocytopenic purpura with rituximab.
Annals of hematology 2007;86(10):711-7.
2007: Wagner Wolfgang; Roderburg Christoph; Wein Frederik; Diehlmann Anke; Frankhauser Maria; Schubert Ralf; Eckstein Volker; Ho Anthony D
Molecular and secretory profiles of human mesenchymal stromal cells and their abilities to maintain primitive hematopoietic progenitors.
Stem cells (Dayton, Ohio) 2007;25(10):2638-47.
2007: Blank Norbert; Schiller Martin; Krienke Stefan; Busse Freja; Schätz Birgit; Ho Anthony D; Kalden Joachim R; Lorenz Hanns-Martin
Atorvastatin inhibits T cell activation through 3-hydroxy-3-methylglutaryl coenzyme A reductase without decreasing cholesterol synthesis.
Journal of immunology (Baltimore, Md. : 1950) 2007;179(6):3613-21.
2007: Hensel Manfred; Zoz Martin; Giesecke Christian; Benner Axel; Neben Kai; Jauch Anna; Stilgenbauer Stephan; Ho Anthony D; Krämer Alwin
High rate of centrosome aberrations and correlation with proliferative activity in patients with untreated B-cell chronic lymphocytic leukemia.
International journal of cancer. Journal international du cancer 2007;121(5):978-83.
2007: Platten M; Opitz C A; Kohlhof P; Hegenbart U; Ho A D; Wick W
Painful neuropathy due to intraneural leukemic spread in a patient with acute myeloid leukemia.
Neurology 2007;69(7):707.
2007: Rebacz Blanka; Larsen Thomas O; Clausen Mads H; Rønnest Mads H; Löffler Harald; Ho Anthony D; Krämer Alwin
Identification of griseofulvin as an inhibitor of centrosomal clustering in a phenotype-based screen.
Cancer research 2007;67(13):6342-50.
2007: Krämer Alwin; Reiter Andreas; Kruth Jens; Erben Philipp; Hochhaus Andreas; Müller Martin; Cross Nicholas C P; Jones Amy V; Ho Anthony D; Hensel Manfred
JAK2-V617F mutation in a patient with Philadelphia-chromosome-positive chronic myeloid leukaemia.
The lancet oncology 2007;8(7):658-60.
2007: Ho Anthony D; Wagner Wolfgang
The beauty of asymmetry: asymmetric divisions and self-renewal in the haematopoietic system.
Current opinion in hematology 2007;14(4):330-6.
2007: Dransfeld C-L; Schaich M; Ho A D; Thiede C; Ehninger G; Mahlknecht U
Class I HDAC SNP analysis in healthy donors compared to AML patients.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2007;21(7):1587-90.
2007: Blank Norbert; Schiller Martin; Krienke Stefan; Wabnitz Guido; Ho Anthony D; Lorenz Hanns-Martin
Cholera toxin binds to lipid rafts but has a limited specificity for ganglioside GM1.
Immunology and cell biology 2007;85(5):378-82.
2007: Schweizer Patrick A; Krause Ulf; Becker Ruediger; Seckinger Anja; Bauer Alexander; Hardt Cornelia; Eckstein Volker; Ho Anthony D; Koenen Michael; Katus Hugo A; Zehelein Joerg
Atrial-radiofrequency catheter ablation mediated targeting of mesenchymal stromal cells.
Stem cells (Dayton, Ohio) 2007;25(6):1546-51.
2007: Ribeiro Daniel; Veldwijk Marlon R; Benner Axel; Laufs Stephanie; Wenz Frederik; Ho Anthony D; Fruehauf Stefan
Differences in functional activity and antigen expression of granulocytes primed in vivo with filgrastim, lenograstim, or pegfilgrastim.
Transfusion 2007;47(6):969-80.
2007: Schiller M; Blank N; Franz S; Gaipl U S; Ho A D; Lorenz Hanns-Martin
Apoptotic bodies derived from apoptotic lymphoblasts contain a distinct pattern of antigens.
Autoimmunity 2007;40(4):340-1.
2007: Heyder P; Bekeredjian-Ding I; Parcina M; Blank N; Ho A D; Herrmann M; Lorenz Hanns-Martin; Heeg K; Schiller M
Purified apoptotic bodies stimulate plasmacytoid dendritic cells to produce IFN-alpha.
Autoimmunity 2007;40(4):331-2.
2007: Fruehauf S; Klaus J; Huesing J; Veldwijk M R; Buss E C; Topaly J; Seeger T; Zeller L W J; Moehler T; Ho A D; Goldschmidt H
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myeloma.
Bone marrow transplantation 2007;39(12):743-50.
2007: Wuchter Patrick; Boda-Heggemann Judit; Straub Beate K; Grund Christine; Kuhn Caecilia; Krause Ulf; Seckinger Anja; Peitsch Wiebke K; Spring Herbert; Ho Anthony D; Franke Werner W
Processus and recessus adhaerentes: giant adherens cell junction systems connect and attract human mesenchymal stem cells.
Cell and tissue research 2007;328(3):499-514.
2007: Kasper Bernd; Egerer Gerlinde; Gronkowski Martina; Haufe Sabine; Lehnert Thomas; Eisenhut Michael; Mechtersheimer Gunhild; Ho Anthony D; Haberkorn Uwe
Functional diagnosis of residual lymphomas after radiochemotherapy with positron emission tomography comparing FDG- and FLT-PET.
Leukemia & lymphoma 2007;48(4):746-53.
2007: Fruehauf Stefan; Topaly Julian; Buss Eike C; Fischer Thomas; Ottmann Oliver G; Emmerich Bertold; Müller Martin C; Schuld Peter; Balleisen Leopold; Hehlmann Rüdiger; Ho Anthony D; Hochhaus Andreas
Imatinib combined with mitoxantrone/etoposide and cytarabine is an effective induction therapy for patients with chronic myeloid leukemia in myeloid blast crisis.
Cancer 2007;109(8):1543-9.
2007: Neben Kai; Ott German; Schweizer Silja; Kalla Jörg; Tews Björn; Katzenberger Tiemo; Hahn Meinhard; Rosenwald Andreas; Ho Anthony D; Müller-Hermelink Hans Konrad; Lichter Peter; Krämer Alwin
Expression of centrosome-associated gene products is linked to tetraploidization in mantle cell lymphoma.
International journal of cancer. Journal international du cancer 2007;120(8):1669-77.
2007: Gottschling Sandra; Saffrich Rainer; Seckinger Anja; Krause Ulf; Horsch Kerstin; Miesala Katrin; Ho Anthony D
Human mesenchymal stromal cells regulate initial self-renewing divisions of hematopoietic progenitor cells by a beta1-integrin-dependent mechanism.
Stem cells (Dayton, Ohio) 2007;25(3):798-806.
2007: Wagner Wolfgang; Wein Frederik; Roderburg Christoph; Saffrich Rainer; Faber Anne; Krause Ulf; Schubert Mario; Benes Vladimir; Eckstein Volker; Maul Holger; Ho Anthony D
Adhesion of hematopoietic progenitor cells to human mesenchymal stem cells as a model for cell-cell interaction.
Experimental hematology 2007;35(2):314-25.
2007: Rodionova Elena; Conzelmann Michael; Maraskovsky Eugene; Hess Michael; Kirsch Michael; Giese Thomas; Ho Anthony D; Zöller Margot; Dreger Peter; Luft Thomas
GSK-3 mediates differentiation and activation of proinflammatory dendritic cells.
Blood 2007;109(4):1584-92.
2007: Hillengass Jens; Wasser Klaus; Delorme Stefan; Kiessling Fabian; Zechmann Christian; Benner Axel; Kauczor Hans-Ulrich; Ho Anthony D; Goldschmidt Hartmut; Moehler Thomas M
Lumbar bone marrow microcirculation measurements from dynamic contrast-enhanced magnetic resonance imaging is a predictor of event-free survival in progressive multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2007;13(2 Pt 1):475-81.
2007: Dreger Peter; Rieger Michael; Seyfarth Bärbel; Hensel Manfred; Kneba Michael; Ho Anthony D; Schmitz Norbert; Pott Christiane
Rituximab-augmented myeloablation for first-line autologous stem cell transplantation for mantle cell lymphoma: effects on molecular response and clinical outcome.
Haematologica 2007;92(1):42-9.
2007: Witzens-Harig Mathias; Heilmann Conny; Hensel Manfred; Kornacker Martin; Benner Axel; Haas Rainer; Fruehauf Stefan; Ho Anthony D
Long-term follow-up of patients with non-Hodgkin lymphoma following myeloablative therapy and autologous transplantation of CD34+-selected peripheral blood progenitor cells.
Stem cells (Dayton, Ohio) 2007;25(1):228-35.
2007: Klaus Jens; Herrmann Doris; Breitkreutz Iris; Hegenbart Ute; Mazitschek Uta; Egerer Gerlinde; Cremer Friedrich W; Lowenthal Ray M; Huesing Johannes; Fruehauf Stefan; Moehler Thomas; Ho Anthony D; Goldschmidt Hartmut
Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation.
European journal of haematology 2007;78(1):21-8.
2007: Kasper Bernd; Dietrich Sascha; Mechtersheimer Gunhild; Ho Anthony D; Egerer Gerlinde
Large institutional experience with dose-intensive chemotherapy and stem cell support in the management of sarcoma patients.
Oncology 2007;73(1-2):58-64.
2007: Faber Anne; Roderburg Christoph; Wein Frederik; Saffrich Rainer; Seckinger Anja; Horsch Kerstin; Diehlmann Anke; Wong Donald; Bridger Gary; Eckstein Volker; Ho Anthony D; Wagner Wolfgang
The Many Facets of SDF-1alpha, CXCR4 Agonists and Antagonists on Hematopoietic Progenitor Cells.
Journal of biomedicine & biotechnology 2007;2007(3):26065.
2006: Schneider M; Munder M; Karakhanova S; Ho A D; Goerner M
The initial phase of graft-versus-host disease is associated with a decrease of CD4+CD25+ regulatory T cells in the peripheral blood of patients after allogeneic stem cell transplantation.
Clinical and laboratory haematology 2006;28(6):382-90.
2006: Schmitt Christina; Grundt Alexander; Buchholtz Christian; Scheuer Lars; Benner Axel; Hensel Manfred; Ho Anthony D; Leo Eugen
One single dose of rituximab added to a standard regimen of CHOP in primary treatment of follicular lymphoma appears to result in a high clearance rate from circulating bcl-2/IgH positive cells: Is the end of molecular monitoring near?
Leukemia research 2006;30(12):1563-8.
2006: Löffler Harald; Rebacz Blanka; Ho Anthony D; Lukas Jiri; Bartek Jiri; Krämer Alwin
Chk1-dependent regulation of Cdc25B functions to coordinate mitotic events.
Cell cycle (Georgetown, Tex.) 2006;5(21):2543-7.
2006: Raab Marc S; Breitkreutz Iris; Hundemer Michael; Benner Axel; Klaus Jens; Hegenbart Ute; Moehler Thomas; Ho Anthony D; Zeier Martin; Goldschmidt Hartmut
The outcome of autologous stem cell transplantation in patients with plasma cell disorders and dialysis-dependent renal failure.
Haematologica 2006;91(11):1555-8.
2006: Mey Ulrich J M; Orlopp Katjana S; Flieger Dimitri; Strehl John W; Ho Anthony D; Hensel Manfred; Bopp Cordula; Gorschlüter Marcus; Wilhelm Martin; Birkmann Josef; Kaiser Ulrich; Neubauer Andreas; Florschütz Axel; Rabe Christian; Hahn Corinna; Glasmacher Axel G; Schmidt-Wolf Ingo G H
Dexamethasone, high-dose cytarabine, and cisplatin in combination with rituximab as salvage treatment for patients with relapsed or refractory aggressive non-Hodgkin's lymphoma.
Cancer investigation 2006;24(6):593-600.
2006: Li Guzi; Hundemer Michael; Wolfrum Sonja; Ho Anthony D; Goldschmidt Hartmut; Witzens-Harig Mathias
Identification and characterization of HLA-class-I-restricted T-cell epitopes in the putative tumor-associated antigens P21-activated serin kinase 2 (PAK2) and cyclin-dependent kinase inhibitor 1A (CDKN1A).
Annals of hematology 2006;85(9):583-90.
2006: Munder Markus; Schneider Henriette; Luckner Claudia; Giese Thomas; Langhans Claus-Dieter; Fuentes Jose M; Kropf Pascale; Mueller Ingrid; Kolb Armin; Modolell Manuel; Ho Anthony D
Suppression of T-cell functions by human granulocyte arginase.
Blood 2006;108(5):1627-34.
2006: Kornacker Martin; Moldenhauer Gerhard; Herbst Markus; Weilguni Edeltraud; Tita-Nwa Freddy; Harter Christoph; Hensel Manfred; Ho Anthony D
Cytokine-induced killer cells against autologous CLL: direct cytotoxic effects and induction of immune accessory molecules by interferon-gamma.
International journal of cancer. Journal international du cancer 2006;119(6):1377-82.
2006: Fruehauf Stefan; Seeger Timon; Maier Patrick; Li Li; Weinhardt Stephan; Laufs Stephanie; Wagner Wolfgang; Eckstein Volker; Bridger Gary; Calandra Gary; Wenz Frederick; Zeller W Jens; Goldschmidt Hartmut; Ho Anthony D
The CXCR4 antagonist AMD3100 releases a subset of G-CSF-primed peripheral blood progenitor cells with specific gene expression characteristics.
Experimental hematology 2006;34(8):1052-9.
2006: Giordano F A; Fehse B; Hotz-Wagenblatt A; Jonnakuty S; del Val C; Appelt J-U; Nagy K Z; Kuehlcke K; Naundorf S; Zander A R; Zeller W J; Ho A D; Fruehauf S; Laufs S
Retroviral vector insertions in T-lymphocytes used for suicide gene therapy occur in gene groups with specific molecular functions.
Bone marrow transplantation 2006;38(3):229-35.
2006: Brune Mats; Castaigne Sylvie; Catalano John; Gehlsen Kurt; Ho Anthony D; Hofmann Wolf-Karsten; Hogge Donna E; Nilsson Bo; Or Reuven; Romero Ana I; Rowe Jacob M; Simonsson Bengt; Spearing Ruth; Stadtmauer Edward A; Szer Jeff; Wallhult Elisabeth; Hellstrand Kristoffer
Improved leukemia-free survival after postconsolidation immunotherapy with histamine dihydrochloride and interleukin-2 in acute myeloid leukemia: results of a randomized phase 3 trial.
Blood 2006;108(1):88-96.
2006: Luft Thomas; Rodionova Elena; Maraskovsky Eugene; Kirsch Michael; Hess Michael; Buchholtz Christian; Goerner Martin; Schnurr Max; Skoda Radek; Ho Anthony D
Adaptive functional differentiation of dendritic cells: integrating the network of extra- and intracellular signals.
Blood 2006;107(12):4763-9.
2006: Schmitt Christina; Balogh Brigitta; Grundt Alexander; Buchholtz Christian; Leo Albrecht; Benner Axel; Hensel Manfred; Ho Anthony D; Leo Eugen
The bcl-2/IgH rearrangement in a population of 204 healthy individuals: occurrence, age and gender distribution, breakpoints, and detection method validity.
Leukemia research 2006;30(6):745-50.
2006: Karakhanova Svetlana; Munder Markus; Schneider Markus; Bonyhadi Mark; Ho Anthony D; Goerner Martin
Highly efficient expansion of human CD4+CD25+ regulatory T cells for cellular immunotherapy in patients with graft-versus-host disease.
Journal of immunotherapy (Hagerstown, Md. : 1997) 2006;29(3):336-49.
2006: Lorenz H-M; Ho A D
[Tissue regeneration and immunosuppression by mesenchymal stem cells]
Deutsche medizinische Wochenschrift (1946) 2006;131(16):892-5.
2006: Engert Andreas; Bredenfeld Henning; Döhner Hartmut; Ho Anthony D; Schmitz Norbert; Berger Dietmar; Bacon Pamela; Skacel Tomas; Easton Valerie; Diehl Volker
Pegfilgrastim support for full delivery of BEACOPP-14 chemotherapy for patients with high-risk Hodgkin's lymphoma: results of a phase II study.
Haematologica 2006;91(4):546-9.
2006: Wagner Wolfgang; Feldmann Robert E; Seckinger Anja; Maurer Martin H; Wein Frederik; Blake Jonathon; Krause Ulf; Kalenka Armin; Bürgers Heinrich F; Saffrich Rainer; Wuchter Patrick; Kuschinsky Wolfgang; Ho Anthony D
The heterogeneity of human mesenchymal stem cell preparations--evidence from simultaneous analysis of proteomes and transcriptomes.
Experimental hematology 2006;34(4):536-48.
2006: Hundemer Michael; Schmidt Stefanie; Condomines Maud; Lupu Alaviana; Hose Dirk; Moos Marion; Cremer Friedrich; Kleist Christian; Terness Peter; Belle Sebastian; Ho Anthony D; Goldschmidt Hartmut; Klein Bernard; Christensen Olaf
Identification of a new HLA-A2-restricted T-cell epitope within HM1.24 as immunotherapy target for multiple myeloma.
Experimental hematology 2006;34(4):486-96.
2006: Ho Anthony D; Hensel Manfred
Pentostatin and purine analogs for indolent lymphoid malignancies.
Future oncology (London, England) 2006;2(2):169-83.
2006: Ho Anthony D; Hensel Manfred
Pentostatin for the treatment of indolent lymphoproliferative disorders.
Seminars in hematology 2006;43(2 Suppl 2):S2-10.
2006: Fiehn C; Wilmes A; Max R; Willand L; Löwe B; Andrassy K; Ho A D; Lorenz H-M
Musculoskeletal and neuropsychiatric manifestations are the main source of persisting affection and organ damage in a German population of patients with systemic lupus erythematosus.
Scandinavian journal of rheumatology 2006;35(2):157-9.
2006: Giebel Bernd; Zhang Tao; Beckmann Julia; Spanholtz Jan; Wernet Peter; Ho Anthony D; Punzel Michael
Primitive human hematopoietic cells give rise to differentially specified daughter cells upon their initial cell division.
Blood 2006;107(5):2146-52.
2006: Harter C; Schulze B; Goldschmidt H; Benner A; Geiss H K; Hoppe-Tichy T; Ho A D; Egerer G
Piperacillin/tazobactam vs ceftazidime in the treatment of neutropenic fever in patients with acute leukemia or following autologous peripheral blood stem cell transplantation: a prospective randomized trial.
Bone marrow transplantation 2006;37(4):373-9.
2006: Mahlknecht Ulrich; Ho Anthony D; Voelter-Mahlknecht Susanne
Chromosomal organization and fluorescence in situ hybridization of the human Sirtuin 6 gene.
International journal of oncology 2006;28(2):447-56.
2006: Kasper Bernd; Ho Anthony D; Egerer Gerlinde
Dose-intensive chemotherapy with stem cell support as a treatment strategy for bone and soft-tissue sarcomas.
Current stem cell research & therapy 2006;1(1):29-35.
2006: Maurer B; Hensel M; Max R; Fiehn C; Ho A D; Lorenz H M
Autologous haematopoietic stem cell transplantation for Behcet's disease with pulmonary involvement: analysis after 5 years of follow up.
Annals of the rheumatic diseases 2006;65(1):127-9.
2006: Ho A D; Wagner W
Bone marrow niche and leukemia.
Ernst Schering Foundation symposium proceedings 2006;(5):125-39.
2006: Kasper Bernd; Kallinowski Birgit; Herrmann Thomas; Lehnert Thomas; Mechtersheimer Gunhild; Geer Thomas; Ho Anthony D; Egerer Gerlinde
Treatment of gastrointestinal stromal tumor with imatinib mesylate: a retrospective single-center experience in Heidelberg.
Digestive diseases (Basel, Switzerland) 2006;24(1-2):207-11.
2006: Mahlknecht U; Ho A D; Letzel S; Voelter-Mahlknecht S
Assignment of the NAD-dependent deacetylase sirtuin 5 gene (SIRT5) to human chromosome band 6p23 by in situ hybridization.
Cytogenetic and genome research 2006;112(3-4):208-12.
2005: Kasper Bernd; Ho Anthony D; Egerer Gerlinde
A new therapeutic approach in patients with advanced sarcoma.
International journal of clinical oncology / Japan Society of Clinical Oncology 2005;10(6):438-40.
2005: Gerull S; Goerner M; Benner A; Hegenbart U; Klein U; Schaefer H; Goldschmidt H; Ho A D
Long-term outcome of nonmyeloablative allogeneic transplantation in patients with high-risk multiple myeloma.
Bone marrow transplantation 2005;36(11):963-9.
2005: Ostendorf Torben; Meinhold Andrea; Harter Christoph; Salwender Hans; Egerer Gerlinde; Geiss Heinrich K; Ho Antony D; Goldschmidt Hartmut
Chlorhexidine and silver-sulfadiazine coated central venous catheters in haematological patients--a double-blind, randomised, prospective, controlled trial.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2005;13(12):993-1000.
2005: Wagner Wolfgang; Wein Frederik; Seckinger Anja; Frankhauser Maria; Wirkner Ute; Krause Ulf; Blake Jonathon; Schwager Christian; Eckstein Volker; Ansorge Wilhelm; Ho Anthony D
Comparative characteristics of mesenchymal stem cells from human bone marrow, adipose tissue, and umbilical cord blood.
Experimental hematology 2005;33(11):1402-16.
2005: Voelter-Mahlknecht Susanne; Ho Anthony D; Mahlknecht Ulrich
FISH-mapping and genomic organization of the NAD-dependent histone deacetylase gene, Sirtuin 2 (Sirt2).
International journal of oncology 2005;27(5):1187-96.
2005: Voelter-Mahlknecht Susanne; Ho Anthony D; Mahlknecht Ulrich
Chromosomal organization and localization of the novel class IV human histone deacetylase 11 gene.
International journal of molecular medicine 2005;16(4):589-98.
2005: Schonland Stefan O; Perz Jolanta B; Hundemer Michael; Hegenbart Ute; Kristen Arnt V; Hund Ernst; Dengler Thomas J; Beimler Jorg; Zeier Martin; Singer Reinhard; Linke Reinhold P; Ho Anthony D; Goldschmidt Hartmut
Indications for high-dose chemotherapy with autologous stem cell support in patients with systemic amyloid light chain amyloidosis.
Transplantation 2005;80(1 Suppl):S160-3.
2005: Hensel Manfred; Villalobos Matthias; Kornacker Martin; Krasniqi Fatime; Ho Anthony D
Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
Clinical lymphoma & myeloma 2005;6(2):131-5.
2005: Wagner Wolfgang; Laufs Stephanie; Blake Jonathon; Schwager Christian; Wu Xiaolin; Zeller Jens W; Ho Anthony D; Fruehauf Stefan
Retroviral integration sites correlate with expressed genes in hematopoietic stem cells.
Stem cells (Dayton, Ohio) 2005;23(8):1050-8.
2005: Wagner Wolfgang; Saffrich Rainer; Wirkner Ute; Eckstein Volker; Blake Jonathon; Ansorge Alexandra; Schwager Christian; Wein Frederik; Miesala Katrin; Ansorge Wilhelm; Ho Anthony D
Hematopoietic progenitor cells and cellular microenvironment: behavioral and molecular changes upon interaction.
Stem cells (Dayton, Ohio) 2005;23(8):1180-91.
2005: Bochtler T; Hensel M; Lorenz H-M; Ho A D; Mahlknecht U
Chronic lymphocytic leukaemia and concomitant relapsing polychondritis: a report on one treatment for the combined manifestation of two diseases.
Rheumatology (Oxford, England) 2005;44(9):1199.
2005: Ho Anthony D; Wagner Wolfgang; Mahlknecht Ulrich
Stem cells and ageing. The potential of stem cells to overcome age-related deteriorations of the body in regenerative medicine.
EMBO reports 2005;6 Spec No():S35-8.
2005: Nikendei C; Schilling T; Nawroth P; Hensel M; Ho A D; Schwenger V; Zeier M; Herzog W; Schellberg D; Katus H A; Dengler T; Stremmel W; Müller M; Jünger J
[Integrated skills laboratory concept for undergraduate training in internal medicine]
Deutsche medizinische Wochenschrift (1946) 2005;130(18):1133-8.
2005: Raab M S; Cremer F W; Breitkreutz I N; Gerull S; Luft T; Benner A; Goerner M; Ho A D; Goldschmidt H; Moos M
Molecular monitoring of tumour load kinetics predicts disease progression after non-myeloablative allogeneic stem cell transplantation in multiple myeloma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16(4):611-7.
2005: Kornacker M; Luft T; Ho A D; Schaefer H-J
Thrombotic microangiopathy after combined autografting-allografting for multiple myeloma - report of three cases.
European journal of haematology 2005;74(3):250-3.
2005: Munder Markus; Mollinedo Faustino; Calafat Jero; Canchado Javier; Gil-Lamaignere Cristina; Fuentes José M; Luckner Claudia; Doschko Gwendolyn; Soler Germán; Eichmann Klaus; Müller Frank-Michael; Ho Anthony D; Goerner Martin; Modolell Manuel
Arginase I is constitutively expressed in human granulocytes and participates in fungicidal activity.
Blood 2005;105(6):2549-56.
2005: Fiehn Christoph; Wunder Andreas; Krienke Stefan; Max Regina; Ho Anthony D; Moehler Thomas
Lack of evidence for inhibition of angiogenesis as a central mechanism of the antiarthritic effect of methotrexate.
Rheumatology international 2005;25(2):108-13.
2005: Fruehauf Stefan; Buss Eike C; Topaly Julian; Kreipe H H; Ho A D
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses - follow-up of three patients.
Haematologica 2005;90(2):ECR08.
2005: Fruehauf Stefan; Buss Eike C; Tropaly Julian; Kreipe H H; Ho A D
Myeloablative conditioning in myelofibrosis using i.v. treosulfan and autologous peripheral blood progenitor cell transplantation with high doses of CD34+ cells results in hematologic responses. A follow-up of three patients.
Haematologica 2005;90(1):ECR08.
2005: Ho Anthony D
Kinetics and symmetry of divisions of hematopoietic stem cells.
Experimental hematology 2005;33(1):1-8.
2005: Fruehauf S; Ho A D
New developments in stem cell biology and therapy. First meeting report from the working group of the German Society for Hematology and Oncology.
Cytotherapy 2005;7(3):301-8.
2005: Kasper Bernd; Ho Anthony D; Egerer Gerlinde
Is there an indication for high-dose chemotherapy in the treatment of bone and soft-tissue sarcoma?
Oncology 2005;68(2-3):115-21.
2004: Perz Jolanta B; Schonland Stefan O; Hundemer Michael; Kristen Arnt V; Dengler Thomas J; Zeier Martin; Linke Reinhold P; Ho Anthony D; Goldschmidt Hartmut
High-dose melphalan with autologous stem cell transplantation after VAD induction chemotherapy for treatment of amyloid light chain amyloidosis: a single centre prospective phase II study.
British journal of haematology 2004;127(5):543-51.
2004: Mei Shaoping; Ho Anthony D; Mahlknecht Ulrich
Role of histone deacetylase inhibitors in the treatment of cancer (Review).
International journal of oncology 2004;25(6):1509-19.
2004: Schneeweiss A; Diel I; Hensel M; Kaul S; Sinn H-P; Unnebrink K; Rudlowski C; Lauschner I; Schuetz F; Egerer G; Haas R; Ho A D; Bastert G
Micrometastatic bone marrow cells at diagnosis have no impact on survival of primary breast cancer patients with extensive axillary lymph node involvement treated with stem cell-supported high-dose chemotherapy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(11):1627-32.
2004: Leo Eugen; Scheuer Lars; Schmidt-Wolf Ingo G H; Kerowgan Mohammed; Schmitt Christina; Leo Albrecht; Baumbach Tanja; Kraemer Alwin; Mey Ulrich; Benner Axel; Parwaresch Reza; Ho Anthony D
Significant thrombocytopenia associated with the addition of rituximab to a combination of fludarabine and cyclophosphamide in the treatment of relapsed follicular lymphoma.
European journal of haematology 2004;73(4):251-7.
2004: Luft Thomas; Maraskovsky Eugene; Schnurr Max; Knebel Katja; Kirsch Michael; Görner Martin; Skoda Radek; Ho Anthony D; Nawroth Peter; Bierhaus Angelika
Tuning the volume of the immune response: strength and persistence of stimulation determine migration and cytokine secretion of dendritic cells.
Blood 2004;104(4):1066-74.
2004: Wagner Wolfgang; Ansorge Alexandra; Wirkner Ute; Eckstein Volker; Schwager Christian; Blake Jonathon; Miesala Katrin; Selig Jan; Saffrich Rainer; Ansorge Wilhelm; Ho Anthony D
Molecular evidence for stem cell function of the slow-dividing fraction among human hematopoietic progenitor cells by genome-wide analysis.
Blood 2004;104(3):675-86.
2004: Kasper B; Lehnert T; Bernd L; Mechtersheimer G; Goldschmidt H; Ho A D; Egerer G
High-dose chemotherapy with autologous peripheral blood stem cell transplantation for bone and soft-tissue sarcomas.
Bone marrow transplantation 2004;34(1):37-41.
2004: Witzens Mathias; Moehler Thomas; Neben Kai; Fruehauf Stefan; Hartschuh Wolfgang; Ho Anthony D; Goldschmidt Hartmut
Development of leukocytoclastic vasculitis in a patient with multiple myeloma during treatment with thalidomide.
Annals of hematology 2004;83(7):467-70.
2004: Fiehn C; Rochel E; Ho A D; Max R
Dose escalation of leflunomide (LEF) to 40 mg once daily in patients with rheumatoid arthritis and insufficient response to standard dose LEF.
Annals of the rheumatic diseases 2004;63(6):746-7.
2004: Löwe Bernd; Willand Levke; Eich Wolfgang; Zipfel Stephan; Ho Anthony D; Herzog Wolfgang; Fiehn Christoph
Psychiatric comorbidity and work disability in patients with inflammatory rheumatic diseases.
Psychosomatic medicine 2004;66(3):395-402.
2004: Seggewiss R; Ho A D; Kraemer A
Remarkable response to rituximab in a patient with atypical CD20(++) mantle cell lymphoma of the bone marrow leading to severe pancytopenia.
Annals of hematology 2004;83(5):316-8.
2004: Hensel Manfred; Buss Eike C; Tiemann Markus; Parwaresch Reza; Libicher Martin; Fruehauf Stefan; Ho Anthony D
Secondary follicular lymphoma of the bone, transformed into large cell lymphoma, in a patient with chronic lymphocytic leukaemia: an uncommon manifestation of Richter's syndrome.
European journal of haematology 2004;72(3):217-21.
2004: Neben Kai; Tews Björn; Wrobel Gunnar; Hahn Meinhard; Kokocinski Felix; Giesecke Christian; Krause Ulf; Ho Anthony D; Krämer Alwin; Lichter Peter
Gene expression patterns in acute myeloid leukemia correlate with centrosome aberrations and numerical chromosome changes.
Oncogene 2004;23(13):2379-84.
2004: Kasper Bernd; Harter Christoph; Meissner Julia; Bellos Frauke; Krasniqi Fatime; Ho Anthony D; Egerer Gerlinde
Prophylactic treatment of known ifosfamide-induced encephalopathy for chemotherapy with high-dose ifosfamide?
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2004;12(3):205-7.
2004: Niemeyer Philipp; Krause Ulf; Fellenberg Jörg; Kasten Philip; Seckinger Anja; Ho Anthony D; Simank Hans-Georg
Evaluation of mineralized collagen and alpha-tricalcium phosphate as scaffolds for tissue engineering of bone using human mesenchymal stem cells.
Cells, tissues, organs 2004;177(2):68-78.
2004: Moehler T M; Hillengass J; Goldschmidt H; Ho A D
Antiangiogenic therapy in hematologic malignancies.
Current pharmaceutical design 2004;10(11):1221-34.
2003: Goldschmidt Hartmut; Egerer Gerlinde; Fruehauf Stefan; Ho Anthony D
[Stem cells in hematology and oncology]
Medizinische Klinik (Munich, Germany : 1983) 2003;98 Suppl 2():11-4.
2003: Zeier Martin; Perz Jolanta; Linke Reinhold P; Donini Ugo; Waldherr Rüdiger; Andrassy Konrad; Ho Anthony D; Goldschmidt Hartmut
No regression of renal AL amyloid in monoclonal gammopathy after successful autologous blood stem cell transplantation and significant clinical improvement.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2644-7.
2003: Harter C; Ostendorf T; Bach A; Egerer G; Goldschmidt H; Ho A D
Peripherally inserted central venous catheters for autologous blood progenitor cell transplantation in patients with haematological malignancies.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2003;11(12):790-4.
2003: Luft Thomas; Moos Marion; Goldschmidt Hartmut; Ho Anthony D; Görner Martin
Dissociation of putative graft-versus-haematopoiesis and graft-versus-myeloma effects in patients with rapidly progressive multiple myeloma.
British journal of haematology 2003;123(4):646-53.
2003: Krämer A; Schweizer S; Neben K; Giesecke C; Kalla J; Katzenberger T; Benner A; Müller-Hermelink H K; Ho A D; Ott G
Centrosome aberrations as a possible mechanism for chromosomal instability in non-Hodgkin's lymphoma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2003;17(11):2207-13.
2003: Schneeweiss Andreas; Sinn Hans-Peter; Ehemann Volker; Khbeis Tanja; Neben Kai; Krause Ulf; Ho Anthony D; Bastert Gunther; Krämer Alwin
Centrosomal aberrations in primary invasive breast cancer are associated with nodal status and hormone receptor expression.
International journal of cancer. Journal international du cancer 2003;107(3):346-52.
2003: Goldschmidt H; Sonneveld P; Cremer F W; van der Holt B; Westveer P; Breitkreutz I; Benner A; Glasmacher A; Schmidt-Wolf I G D; Martin H; Hoelzer D; Ho A D; Lokhorst H M;
Joint HOVON-50/GMMG-HD3 randomized trial on the effect of thalidomide as part of a high-dose therapy regimen and as maintenance treatment for newly diagnosed myeloma patients.
Annals of hematology 2003;82(10):654-9.
2003: Hensel Manfred; Kornacker Martin; Yammeni Sophie; Egerer Gerlinde; Ho Anthony D
Disease activity and pretreatment, rather than hypogammaglobulinaemia, are major risk factors for infectious complications in patients with chronic lymphocytic leukaemia.
British journal of haematology 2003;122(4):600-6.
2003: Hoepfner Sabine; Goerner Martin; Benner Axel; Henning Peter; Ho Anthony D
Unrelated donor transplantation after reduced intensity conditioning as an approach for patients lacking related donors for allogeneic stem cell transplantation.
Journal of hematotherapy & stem cell research 2003;12(3):331-9.
2003: Goerner Martin; Weber-Nordt Renate; Hoepfner Sabine; Benner Axel; Luft Thomas; Ho A D
Addition of a low fixed number of CD3+ cells to CD34-enriched allografts: effects on engraftment, graft-versus-host disease, and survival after related and unrelated peripheral stem cell transplantation.
Journal of hematotherapy & stem cell research 2003;12(3):309-20.
2003: Fruehauf S; Topaly J; Schad M; Paschka P; Gschaidmeier H; Zeller W J; Hochhaus A; Ho A D
Imatinib restores expression of CD62L in BCR-ABL-positive cells.
Journal of leukocyte biology 2003;73(5):600-3.
2003: Ho Anthony D; Punzel Michael
Hematopoietic stem cells: can old cells learn new tricks?
Journal of leukocyte biology 2003;73(5):547-55.
2003: Hensel Manfred; Ho Anthony D
Successful treatment of a patient with hairy cell leukemia and pentostatin-induced autoimmune thrombocytopenia with rituximab.
American journal of hematology 2003;73(1):37-40.
2003: Fiehn C; Hajjar Y; Mueller K; Waldherr R; Ho A D; Andrassy K
Improved clinical outcome of lupus nephritis during the past decade: importance of early diagnosis and treatment.
Annals of the rheumatic diseases 2003;62(5):435-9.
2003: Punzel Michael; Liu Daihong; Zhang Tao; Eckstein Volker; Miesala Katrin; Ho Anthony D
The symmetry of initial divisions of human hematopoietic progenitors is altered only by the cellular microenvironment.
Experimental hematology 2003;31(4):339-47.
2003: Fruehauf Stefan; Topaly Julian; Villalobos Matthias; Veldwijk Marlon R; Laufs Stephanie; Ho Anthony D
Quantitative real-time polymerase chain reaction shows that treatment with interferon reduces the initially upregulated PRV-1 expression in polycythemia vera patients.
Haematologica 2003;88(3):349-51.
2003: Laufs Stephanie; Gentner Bernhard; Nagy K Zsuzsanna; Jauch Anna; Benner Axel; Naundorf Sonja; Kuehlcke Klaus; Schiedlmeier Bernhard; Ho Anthony D; Zeller W Jens; Fruehauf Stefan
Retroviral vector integration occurs in preferred genomic targets of human bone marrow-repopulating cells.
Blood 2003;101(6):2191-8.
2003: Egerer G; Harter C; Karthaus M; Ho A D; Goldschmidt H
Use of erythropoietin in patients with multiple myeloma.
Onkologie 2003;26(1):80-4.
2003: Egerer Gerlinde; Goldschmidt Hartmut; Zoz Martin; Ho Anthony D
Autologous bone marrow transplantation in adult patients with acute lymphoblastic leukemia.
Leukemia & lymphoma 2003;44(1):9-14.
2003: Hensel Manfred; Fiehn Christoph; Ho Anthony D
[Stem cell transplantation in primary systemic vasculitis]
Medizinische Klinik (Munich, Germany : 1983) 2003;98(1):13-8.
2003: Neben Kai; Giesecke Christian; Schweizer Silja; Ho Anthony D; Krämer Alwin
Centrosome aberrations in acute myeloid leukemia are correlated with cytogenetic risk profile.
Blood 2003;101(1):289-91.
2003: Seggewiss Ruth; Buss Eike Christian; Herrmann Doris; Goldschmidt Hartmut; Ho Anthony Dick; Fruehauf Stefan
Kinetics of peripheral blood stem cell mobilization following G-CSF-supported chemotherapy.
Stem cells (Dayton, Ohio) 2003;21(5):568-74.
2002: Fruehauf Stefan; Topaly Julian; Buss Eike C; Schad Moritz; Goerner Martin; Zeller W Jens; Ho Anthony D
Combination of imatinib and established antileukemic treatment modalities for otherwise refractory BCR-ABL positive lymphoblastic leukemia.
Haematologica 2002;87(12):ECR38.
2002: Neben Kai; Moehler Thomas; Benner Axel; Kraemer Alwin; Egerer Gerlinde; Ho Anthony D; Goldschmidt Hartmut
Dose-dependent effect of thalidomide on overall survival in relapsed multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(11):3377-82.
2002: Egerer G; Goldschmidt H; Hensel M; Harter C; Schneeweiss A; Ehrhard I; Bastert G; Ho A D
Continuous infusion of ceftazidime for patients with breast cancer and multiple myeloma receiving high-dose chemotherapy and peripheral blood stem cell transplantation.
Bone marrow transplantation 2002;30(7):427-31.
2002: Krämer A; Schultheis B; Bergmann J; Willer A; Hegenbart U; Ho A D; Goldschmidt H; Hehlmann R
Alterations of the cyclin D1/pRb/p16(INK4A) pathway in multiple myeloma.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(9):1844-51.
2002: Neben Kai; Mytilineos Joannis; Moehler Thomas M; Preiss Astrid; Kraemer Alwin; Ho Anthony D; Opelz Gerhard; Goldschmidt Hartmut
Polymorphisms of the tumor necrosis factor-alpha gene promoter predict for outcome after thalidomide therapy in relapsed and refractory multiple myeloma.
Blood 2002;100(6):2263-5.
2002: Leo E; Krämer A; Hochhaus A; Krasniqi F; Hehlmann R; Ho A D
Gangrene of the toes in a patient with chronic myelogenous leukemia after long-term hydroxyurea therapy.
Annals of hematology 2002;81(8):467-9.
2002: Hensel Manfred; Schneeweiss Andreas; Sinn Hans-Peter; Egerer Gerlinde; Solomayer Erich; Haas Rainer; Bastert Gunther; Ho Anthony D
P53 is the strongest predictor of survival in high-risk primary breast cancer patients undergoing high-dose chemotherapy with autologous blood stem cell support.
International journal of cancer. Journal international du cancer 2002;100(3):290-6.
2002: Abdallah A; Egerer G; Weber-Nordt R M; Körbling M; Haas R; Ho A D
Long-term outcome in acute myelogenous leukemia autografted with mafosfamide-purged marrow in a single institution: adverse events and incidence of secondary myelodysplasia.
Bone marrow transplantation 2002;30(1):15-22.
2002: Schneeweiss A; Hensel M; Sinn P; Khbeis T; Haas R; Bastert G; Ho A D
Characteristics associated with long-term progression-free survival following high-dose chemotherapy in metastatic breast cancer and influence of chemotherapy dose.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(5):679-88.
2002: Punzel Michael; Zhang Tao; Liu Daihong; Eckstein Volker; Ho Anthony D
Functional analysis of initial cell divisions defines the subsequent fate of individual human CD34(+)CD38(-) cells.
Experimental hematology 2002;30(5):464-72.
2002: Krämer A; Neben K; Ho A D
Centrosome replication, genomic instability and cancer.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2002;16(5):767-75.
2002: Topaly J; Fruehauf S; Ho A D; Zeller W J
Rationale for combination therapy of chronic myelogenous leukaemia with imatinib and irradiation or alkylating agents: implications for pretransplant conditioning.
British journal of cancer 2002;86(9):1487-93.
2002: Görner M; Kordelas L; Thalheimer M; Luft T; Pfeiffer S; Ustaoglu F; Punzel M; Weber-Nordt R; Moos M; Goldschmidt H; Ho A D
Stable mixed chimerism after T cell-depleted allogeneic hematopoietic stem cell transplantation using conditioning with low-dose total body irradiation and fludarabine.
Bone marrow transplantation 2002;29(7):621-4.
2002: Görner M; Seggewiss R; Schlenker T; Stremmel W; Ho A D
A case of severe refractory thrombotic thrombocytic purpura responding to treatment with 13-cis retinoic acid.
British journal of haematology 2002;117(1):249-51.
2002: Fruehauf S; Srbic K; Seggewiss R; Topaly J; Ho A D
Functional characterization of podia formation in normal and malignant hematopoietic cells.
Journal of leukocyte biology 2002;71(3):425-32.
2002: Gemmel C; Cremer F W; Weis M; Witzens M; Moldenhauer G; Koniczek K-H; Imbach U; Ho A D; Moos M; Goldschmidt H
Anti-CD20 antibody as consolidation therapy in a patient with primary plasma cell leukemia after high-dose therapy and autologous stem cell transplantation.
Annals of hematology 2002;81(2):119-23.
2002: Kornacker M; Kraemer A; Leo E; Ho A D
Occurrence of sarcoidosis subsequent to chemotherapy for non-Hodgkin's lymphoma: report of two cases.
Annals of hematology 2002;81(2):103-5.
2002: Hensel M; Egerer G; Schneeweiss A; Goldschmidt H; Ho A D
Quality of life and rehabilitation in social and professional life after autologous stem cell transplantation.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2002;13(2):209-17.
2002: Perz Jolanta; Topaly Julian; Fruehauf Stefan; Hensel Manfred; Ho Anthony D
Level of CD 20-expression and efficacy of rituximab treatment in patients with resistant or relapsing B-cell prolymphocytic leukemia and B-cell chronic lymphocytic leukemia.
Leukemia & lymphoma 2002;43(1):149-51.
2002: Harter Christoph; Salwender Hans Jürgen; Bach Alfons; Egerer Gerlinde; Goldschmidt Hartmut; Ho Anthony D
Catheter-related infection and thrombosis of the internal jugular vein in hematologic-oncologic patients undergoing chemotherapy: a prospective comparison of silver-coated and uncoated catheters.
Cancer 2002;94(1):245-51.
2002: Hensel Manfred; Schneeweiss Andreas; Sinn Hans-Peter; Egerer Gerlinde; Kornacker Martin; Solomayer Erich; Haas Rainer; Bastert Gunther; Ho Anthony D
Stem cell dose and tumorbiologic parameters as prognostic markers for patients with metastatic breast cancer undergoing high-dose chemotherapy with autologous blood stem cell support.
Stem cells (Dayton, Ohio) 2002;20(1):32-40.
2001: Krämer A; Ho A D
Centrosome aberrations and cancer.
Onkologie 2001;24(6):538-44.
2001: Moehler T M; Neben K; Ho A D; Goldschmidt H
Angiogenesis in hematologic malignancies.
Annals of hematology 2001;80(12):695-705.
2001: Moehler T M; Neben K; Benner A; Egerer G; Krasniqi F; Ho A D; Goldschmidt H
Salvage therapy for multiple myeloma with thalidomide and CED chemotherapy.
Blood 2001;98(13):3846-8.
2001: Neben K; Moehler T; Kraemer A; Benner A; Egerer G; Ho A D; Goldschmidt H
Response to thalidomide in progressive multiple myeloma is not mediated by inhibition of angiogenic cytokine secretion.
British journal of haematology 2001;115(3):605-8.
2001: Neben K; Werner M; Bernd L; Ewerbeck V; Delling G; Ho A D
A man with hereditary exostoses and high-grade non-Hodgkin's lymphoma of the bone.
Annals of hematology 2001;80(11):682-4.
2001: Lipinski E; Cremer F W; Ho A D; Goldschmidt H; Moos M
Molecular monitoring of the tumor load predicts progressive disease in patients with multiple myeloma after high-dose therapy with autologous peripheral blood stem cell transplantation.
Bone marrow transplantation 2001;28(10):957-62.
2001: Neben K; Moehler T; Egerer G; Kraemer A; Hillengass J; Benner A; Ho A D; Goldschmidt H
High plasma basic fibroblast growth factor concentration is associated with response to thalidomide in progressive multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(9):2675-81.
2001: Moehler T M; Hawighorst H; Neben K; Egerer G; Hillengass J; Max R; Benner A; Ho A D; van Kaick G; Goldschmidt H
Bone marrow microcirculation analysis in multiple myeloma by contrast-enhanced dynamic magnetic resonance imaging.
International journal of cancer. Journal international du cancer 2001;93(6):862-8.
2001: Egerer G; Sauerland K; Ho A D
Remarkable response to rituximab in a 72-year-old patient with refractory non-Hodgkin's lymphoma and marrow aplasia.
Leukemia & lymphoma 2001;42(3):551-3.
2001: Egerer G; Hegenbart U; Salwender H; Haas R; Hahn U; Schmier J W; Ho A D; Goldschmidt H
Outpatient treatment of multiple myeloma with a combination of vincristine, Adriamycin and dexamethasone.
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer 2001;9(5):380-5.
2001: Egerer G; Hensel M; Ho A D
Infectious complications in chronic lymphoid malignancy.
Current treatment options in oncology 2001;2(3):237-44.
2001: Buss E C; Schiedlmeier B; Ho A D; Zeller W J; Fruehauf S
The FBMD-1 stroma cell line secretes a unique moiety which can increase retroviral transduction of lineage-committed and primitive human peripheral blood progenitor cells.
Cancer gene therapy 2001;8(6):440-9.
2001: Punzel M; Ho A D
Divisional history and pluripotency of human hematopoietic stem cells.
Annals of the New York Academy of Sciences 2001;938():72-81; discussion 81-2.
2001: Fruehauf S; Steiger S; Topaly J; Ho A D
Pulmonary artery hypertension during interferon-alpha therapy for chronic myelogenous leukemia.
Annals of hematology 2001;80(5):308-10.
2001: Egerer G; Goldschmidt H; Müller I; Karthaus M; Günther H; Ho A D
Ceftriaxone for the treatment of febrile episodes in nonneutropenic patients with hematooncological disease or HIV infection: comparison of outpatient and inpatient care.
Chemotherapy 2001;47(3):219-25.
2001: Abdallah A; Egerer G; Goldschmidt H; Wannenmacher M; Körbling M; Ho A D
Continuous complete remission in adult patients with acute lymphocytic leukaemia at a median observation of 12 years after autologous bone marrow transplantation.
British journal of haematology 2001;112(4):1012-5.
2001: Egerer G; Lehnert T; Max R; Naeher H; Keilholz U; Ho A D
Pilot study of hepatic intraarterial fotemustine chemotherapy for liver metastases from uveal melanoma: a single-center experience with seven patients.
International journal of clinical oncology / Japan Society of Clinical Oncology 2001;6(1):25-8.
2001: Hensel M; Breitbart A; Ho A D
Autologous hematopoietic stem-cell transplantation for Behçet's disease with pulmonary involvement.
The New England journal of medicine 2001;344(1):69.
2001: Egerer G; Witzens M; Spaeth A; Breitbart A; Möller P; Goldschmidt H; Ho A D
Successful treatment of bronchiolitis obliterans organizing pneumonia with low-dose methotrexate in a patient with Hodgkin's disease.
Oncology 2001;61(1):23-7.
2001: Schneeweiss A; Goerner R; Hensel M A; Lauschner I; Sinn P; Kaul S; Egerer G; Beldermann F; Geberth M; Solomayer E; Grischke E M; Haas R; Ho A D; Bastert G
Tandem high-dose chemotherapy in high-risk primary breast cancer: a multivariate analysis and a matched-pair comparison with standard-dose chemotherapy.
Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation 2001;7(6):332-42.
2001: Schneeweiss A; Hensel M; Goerner R; Khbeis T; Hohaus S; Egerer G; Solomayer E; Haas R; Grischke E M; Bastert G; Ho A D
Comparison of double and triple high-dose chemotherapy with autologous blood stem cell transplantation in patients with metastatic breast cancer.
Stem cells (Dayton, Ohio) 2001;19(2):151-60.
2000: Neben K; Hohaus S; Goldschmidt H; Egerer G; Voso M T; Ho A D; Haas R
High-dose therapy with peripheral blood stem cell transplantation for patients with relapsed or refractory Hodgkin's disease: long-term outcome and prognostic factors.
Annals of hematology 2000;79(10):547-55.
2000: Cremer F W; Ehrbrecht E; Kiel K; Benner A; Hegenbart U; Ho A D; Goldschmidt H; Moos M
Evaluation of the kinetics of the bone marrow tumor load in the course of sequential high-dose therapy assessed by quantitative PCR as a predictive parameter in patients with multiple myeloma.
Bone marrow transplantation 2000;26(8):851-8.
2000: Moehler T M; Hawighorst H; Neben K; Egerer G; Benner A; Hillengass J; Max R; Ho A D; Goldschmidt H; van Kaick G
[Functional magnetic resonance tomography in the diagnosis and therapy monitoring in multiple myeloma]
Der Radiologe 2000;40(8):723-30.
2000: Fiehn C; Wettschureck N; Krauthoff A; Haas R; Ho A D
Bone marrow-derived cells as carriers of recombinant immunomodulatory cytokine genes to lymphoid organs.
Cancer gene therapy 2000;7(8):1105-12.
2000: Bösing T; Bellos F; Cremer F W; Gemmel C; Moldenhauer G; Ho A D; Goldschmidt H; Moos M
CD19+ and CD20+ B cells from the peripheral blood of patients with multiple myeloma are not infected with human herpesvirus 8.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 2000;14(7):1330-1.
2000: Egerer G; Goldschmidt H; Salwender H; Hegenbart U; Ehrhard I; Haas R; Ho A D
Efficacy of continuous infusion of ceftazidime for patients with neutropenic fever after high-dose chemotherapy and peripheral blood stem cell transplantation.
International journal of antimicrobial agents 2000;15(2):119-23.
2000: Voso M T; Pantel G; Weis M; Schmidt P; Martin S; Moos M; Ho A D; Haas R; Hohaus S
In vivo depletion of B cells using a combination of high-dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma.
British journal of haematology 2000;109(4):729-35.
2000: Goldschmidt H; Egerer G; Ho A D
Autologous and allogeneic stem cell transplantation in multiple myeloma.
Bone marrow transplantation 2000;25 Suppl 2():S25-6.
2000: Voso M T; Martin S; Hohaus S; Abdallah A; Schlenk R F; Ho A D; Haas R
Prognostic factors for the clinical outcome of patients with follicular lymphoma following high-dose therapy and peripheral blood stem cell transplantation (PBSCT).
Bone marrow transplantation 2000;25(9):957-64.
2000: Ho A D; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Pentostatin (Nipent) in T-cell malignancies. Leukemia Cooperative Group and the European Organization for Research and Treatment of Cancer.
Seminars in oncology 2000;27(2 Suppl 5):52-7.
2000: Bashey A; Corringham S; Garrett J; Lane T A; Gilpin E A; Corringham R E; Law P; Ho A D
A phase II study of two cycles of high-dose chemotherapy with autologous stem cell support in patients with metastatic breast cancer who meet eligibility criteria for a single cycle.
Bone marrow transplantation 2000;25(5):519-24.
2000: Bashey A; Corringham S; Gilpin E; Fields K K; Smilee R C; DeFrancisco C; Santos-Ada O; Holman P; Carrier E; Ho A D; Lane T A; Ball E D; Janssen W E; Law P
Simultaneous administration of G-CSF and GM-CSF for re-mobilization in patients with inadequate initial progenitor cell collections for autologous transplantation.
Cytotherapy 2000;2(3):195-200.
2000: Egerer G; Hegenbart U; Salwender H J; Goldschmidt H; Ho A D
Treatment of chemotherapy-induced emesis.
Antibiotics and chemotherapy 2000;50():171-83.
2000: Salwender H J; Egerer G; Bach A; Hahn U; Goldschmidt H; Ho A D
Central venous catheter-related complications.
Antibiotics and chemotherapy 2000;50():133-43.
2000: Stilgenbauer F; Egerer G; Karthaus M; Goldschmidt H; Ho A D
Recombinant human erythropoietin in the treatment of cancer.
Antibiotics and chemotherapy 2000;50():106-14.
2000: Egerer G; Karthaus M; Goldschmidt H; Ho A D
Antimicrobial therapy in neutropenic patients.
Antibiotics and chemotherapy 2000;50():20-5.
1999: Ho A D; Suciu S; Stryckmans P; De Cataldo F; Willemze R; Thaler J; Peetermans M; Döhner H; Solbu G; Dardenne M; Zittoun R
Pentostatin in T-cell malignancies--a phase II trial of the EORTC. Leukemia Cooperative Group.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(12):1493-8.
1999: Stilgenbauer S; Bullinger L; Benner A; Wildenberger K; Bentz M; Döhner K; Ho A D; Lichter P; Döhner H
Incidence and clinical significance of 6q deletions in B cell chronic lymphocytic leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1999;13(9):1331-4.
1999: Rottenburger C; Kiel K; Bösing T; Cremer F W; Moldenhauer G; Ho A D; Goldschmidt H; Moos M
Clonotypic CD20+ and CD19+ B cells in peripheral blood of patients with multiple myeloma post high-dose therapy and peripheral blood stem cell transplantation.
British journal of haematology 1999;106(2):545-52.
1999: Fruehauf S; Schmitt K; Veldwijk M R; Topaly J; Benner A; Zeller W J; Ho A D; Haas R
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patients.
British journal of haematology 1999;105(3):786-94.
1999: Bellos F; Goldschmidt H; Dörner M; Ho A D; Moos M
Bone marrow derived dendritic cells from patients with multiple myeloma cultured with three distinct protocols do not bear Kaposi's sarcoma associated herpesvirus DNA.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(3):323-7.
1999: Law P; Lane T A; Gervaix A; Looney D; Schwarz L; Young D; Ramos S; Wong-Staal F; Recktenwald D; Ho A D
Mobilization of peripheral blood progenitor cells for human immunodeficiency virus-infected individuals.
Experimental hematology 1999;27(1):147-54.
1999: Lane T A; Ho A D; Bashey A; Peterson S; Young D; Law P
Mobilization of blood-derived stem and progenitor cells in normal subjects by granulocyte-macrophage- and granulocyte-colony-stimulating factors.
Transfusion 1999;39(1):39-47.
1999: Kasper B; Fruehauf S; Schiedlmeier B; Buchdunger E; Ho A D; Zeller W J
Favorable therapeutic index of a p210(BCR-ABL)-specific tyrosine kinase inhibitor; activity on lineage-committed and primitive chronic myelogenous leukemia progenitors.
Cancer chemotherapy and pharmacology 1999;44(5):433-8.
1998: Huang S; Law P; Young D; Ho A D
Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
Experimental hematology 1998;26(12):1162-71.
1998: Li X; Gervaix A; Kang D; Law P; Spector S A; Ho A D; Wong-Staal F
Gene therapy targeting cord blood-derived CD34+ cells from HIV-exposed infants: preclinical studies.
Gene therapy 1998;5(2):233-9.
1997: Gervaix A; Schwarz L; Law P; Ho A D; Looney D; Lane T; Wong-Staal F
Gene therapy targeting peripheral blood CD34+ hematopoietic stem cells of HIV-infected individuals.
Human gene therapy 1997;8(18):2229-38.
1996: Ho A D; Young D; Maruyama M; Corringham R E; Mason J R; Thompson P; Grenier K; Law P; Terstappen L W; Lane T
Pluripotent and lineage-committed CD34+ subsets in leukapheresis products mobilized by G-CSF, GM-CSF vs. a combination of both.
Experimental hematology 1996;24(13):1460-8.
1996: Glück S; Chadderton A; Ho A D
The selective uptake of benzoporphyrin derivative mono-acid ring A results in differential cell kill of multiple myeloma cells in vitro.
Photochemistry and photobiology 1996;63(6):846-53.
1996: Agrawal Y P; Agrawal R S; Sinclair A M; Young D; Maruyama M; Levine F; Ho A D
Cell-cycle kinetics and VSV-G pseudotyped retrovirus-mediated gene transfer in blood-derived CD34+ cells.
Experimental hematology 1996;24(6):738-47.
1996: Ho A D; Young D; Maruyama M; Law P; Corringham R E; Mason J R; Oldham F; Mills B; Terstappen L; Lane T A
Mobilization and purification of CD34+ cells from normal donors-regimens with G-CSF, GM-CSF, or a combination of both.
Bone marrow transplantation 1996;17 Suppl 2():S34-7.
1995: Ho A D; Li X; Lane T A; Yu M; Law P; Wong-Staal F
Stem cells as vehicles for gene therapy: novel strategy for HIV infection.
Stem cells (Dayton, Ohio) 1995;13 Suppl 3():100-5.
1995: Yu M; Leavitt M C; Maruyama M; Yamada O; Young D; Ho A D; Wong-Staal F
Intracellular immunization of human fetal cord blood stem/progenitor cells with a ribozyme against human immunodeficiency virus type 1.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(3):699-703.
1994: Ho A D; Maruyama M; Maghazachi A; Mason J R; Glück S; Corringham R E
Soluble CD4, soluble CD8, soluble CD25, lymphopoieitic recovery, and endogenous cytokines after high-dose chemotherapy and blood stem cell transplantation.
Blood 1994;84(10):3550-7.
1994: al-Aoukaty A; Giaid A; Sinoff C; Ho A D; Maghazachi A A
Priming effects of granulocyte-macrophage colony-stimulating factor are coupled to cholera toxin-sensitive guanine nucleotide binding protein in human T lymphocytes.
Blood 1994;83(5):1299-309.
1993: Haas R; Ho A D; Del Valle F; Fischer J T; Ehrhardt R; Döhner H; Witt B; Huberts H; Kaplan E; Hunstein W
Idarubicin/cytosine arabinoside and mitoxantrone/etoposide for the treatment of de novo acute myelogenous leukemia.
Seminars in oncology 1993;20(6 Suppl 8):20-6.
1993: Ho A D; Glück S; Germond C; Sinoff C; Dietz G; Maruyama M; Corringham R E
Optimal timing for collections of blood progenitor cells following induction chemotherapy and granulocyte-macrophage colony-stimulating factor for autologous transplantation in advanced breast cancer.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(11):1738-46.
1993: Döhner H; Ho A D; Thaler J; Stryckmans P; Sonneveld P; de Witte T; Lechner K; Lauria F; Bödewadt-Radzun S; Suciu S
Pentostatin in prolymphocytic leukemia: phase II trial of the European Organization for Research and Treatment of Cancer Leukemia Cooperative Study Group.
Journal of the National Cancer Institute 1993;85(8):658-62.
1993: Straka C; Mielke B; Eichelmann A; Trede I; Ho A D; Möller P
Bcl-2 gene rearrangements in primary B-cell lymphoma of the gastrointestinal tract reveal follicular lymphoma as a subtype.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1993;7(2):268-73.
1993: Sebok K; Woodside D; al-Aoukaty A; Ho A D; Gluck S; Maghazachi A A
IL-8 induces the locomotion of human IL-2-activated natural killer cells. Involvement of a guanine nucleotide binding (Go) protein.
Journal of immunology (Baltimore, Md. : 1950) 1993;150(4):1524-34.
1992: Ho A D; Moritz T; Rensch K; Hunstein W; Kirchner H
Deficiency in interferon production of peripheral blood leukocytes from patients with non-Hodgkin lymphoma.
Journal of interferon research 1992;Spec No():61-9.
1992: Ho A D; Klotzbücher A; Gross A; Dietz G; Mestan J; Jakobsen H; Hunstein W
Induction of intracellular and plasma 2',5'-oligoadenylate synthetase by pentostatin.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1992;6(3):209-14.
1991: Bentz M; Döhner H; Gückel F; Semmler W; Kauczor H U; van Kaick G; Ho A D; Hunstein W
Assessment of bone marrow infiltration by magnetic resonance imaging in patients with hairy cell leukemia treated with pentostatin or alpha-interferon.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1991;5(10):905-7.
1991: Weiss C; Wulf G; Ho A D; Hunstein W
Decrease in soluble CD8 antigen levels in splenectomized patients as an index for reduced suppressor/cytotoxic cell activity.
Immunology letters 1991;30(1):113-8.
1991: Ho A D; Brado B; Haas R; Hunstein W
Etoposide in acute leukemia. Past experience and future perspectives.
Cancer 1991;67(1 Suppl):281-4.
1990: Ho A D; Del Valle F; Haas R; Engelhard M; Hiddemann W; Rückle H; Schlimok G; Thiel E; Andreesen R; Fiedler W
Sequential studies on the role of mitoxantrone, high-dose cytarabine, and recombinant human granulocyte-macrophage colony-stimulating factor in the treatment of refractory non-Hodgkin's lymphoma.
Seminars in oncology 1990;17(6 Suppl 10):14-8; discussion 18-9.
1990: Ho A D; Pezzutto A; Hunstein W
[The therapy of hairy-cell leukemia]
Deutsche medizinische Wochenschrift (1946) 1990;115(41):1556-9.
1990: Hiddemann W; Büchner T; Heil G; Schumacher K; Diedrich H; Maschmeyer G; Ho A D; Planker M; Gerith-Stolzenburg S; Donhuijsen-Ant R
Treatment of refractory acute lymphoblastic leukemia in adults with high dose cytosine arabinoside and mitoxantrone (HAM).
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(9):637-40.
1990: Ho A D; Thaler J; Stryckmans P; Coiffier B; Luciani M; Sonneveld P; Lechner K; Rodenhuis S; Peetermans M E; deCataldo F
Pentostatin in refractory chronic lymphocytic leukemia: a phase II trial of the European Organization for Research and Treatment of Cancer.
Journal of the National Cancer Institute 1990;82(17):1416-20.
1990: Ho A D; Thaler J; Willemze R; Lauria F; Mandelli F; Stryckmans P; de Cataldo F; Baccarani M; Peetermans M E; de Witte T
Pentostatin (2'-deoxycoformycin) for the treatment of lymphoid neoplasms.
Cancer treatment reviews 1990;17(2-3):213-5.
1990: Ho A D; Del Valle F; Engelhard M; Hiddemann W; Rückle H; Schlimok G; Haas R; Thiel E; Andreesen R; Fiedler W
Mitoxantrone/high-dose Ara-C and recombinant human GM-CSF in the treatment of refractory non-Hodgkin's lymphoma. A pilot study.
Cancer 1990;66(3):423-30.
1990: Ho A D; Männel D N; Wulf G; Kirchner H; Gundt A; Trede I; Rensch K; Hunstein W
Long-term effects of 2'-deoxycoformycin treatment on cytokine production in patients with hairy cell leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(8):584-9.
1990: Körbling M; Holle R; Haas R; Knauf W; Dörken B; Ho A D; Kuse R; Pralle H; Fliedner T M; Hunstein W
Autologous blood stem-cell transplantation in patients with advanced Hodgkin's disease and prior radiation to the pelvic site.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):978-85.
1990: Thaler J; Dietze O; Faber V; Greil R; Gastl G; Denz H; Ho A D; Huber H
Monoclonal antibody B-ly7: a sensitive marker for detection of minimal residual disease in hairy cell leukemia.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1990;4(3):170-6.
1990: Ho A D; Grossman M; Trümper L; Pezzutto A; Pralle H; Boedewadt-Radzun S; Papendick U; Göd B; Zwingers T; Hunstein W
Clinical implications of increased plasma levels of CD8 in patients with hairy cell leukemia.
Blood 1990;75(5):1119-24.
1990: Haas R; Ho A D; Bredthauer U; Cayeux S; Egerer G; Knauf W; Hunstein W
Successful autologous transplantation of blood stem cells mobilized with recombinant human granulocyte-macrophage colony-stimulating factor.
Experimental hematology 1990;18(2):94-8.
1990: Ho A D; Haas R; Wulf G; Knauf W; Ehrhardt R; Heilig B; Körbling M; Schulz G; Hunstein W
Activation of lymphocytes induced by recombinant human granulocyte-macrophage colony-stimulating factor in patients with malignant lymphoma.
Blood 1990;75(1):203-12.
1990: Weiss C; Ho A D; Hiller E; Thiel E; Schlag R; Lipp T; Herrmann R; Musch E; Termander B; Hunstein W
Prognostic significance of glucocorticoid receptor determination in patients with chronic lymphocytic leukemia and immunocytoma--lack of a positive correlation between receptor levels and clinical responsiveness.
Leukemia research 1990;14(4):327-32.
1990: Knauf W U; Ho A D; Körbling M; Hunstein W
Combination therapy with mitoxantrone and etoposide in adult acute myelogenous leukemia.
Haematology and blood transfusion 1990;33():314-5.
1989: Körbling M; Hunstein W; Fliedner T M; Cayeux S; Dörken B; Fehrentz D; Haas R; Ho A D; Keilholz U; Knauf W
Disease-free survival after autologous bone marrow transplantation in patients with acute myelogenous leukemia.
Blood 1989;74(6):1898-904.
1989: Ho A D; Thaler J; Mandelli F; Lauria F; Zittoun R; Willemze R; McVie G; Marmont A M; Prümmer O; Stryckmans P
Response to pentostatin in hairy-cell leukemia refractory to interferon-alpha. The European Organization for Research and Treatment of Cancer Leukemia Cooperative Group.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1989;7(10):1533-8.
1989: Ho A D; del Valle F; Rückle H; Schwammborn J; Schlimok G; Hiddemann W; Meusers P; Thiel E; Dörken B; Hunstein W
Mitoxantrone and high-dose cytarabine as salvage therapy for refractory non-Hodgkin's lymphoma.
Cancer 1989;64(7):1388-92.
1989: Ho A D; Grossmann M; Knauf W; Martin H; Trümper L; Zwingers T; Sonnen R; Pralle H; Hunstein W
Plasma levels of soluble CD8 antigen and interleukin-2 receptor antigen in patients with hairy cell leukemia, relationship with splenectomy and with clinical response to therapy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1989;3(10):718-23.
1989: Döhner H; Gückel F; Knauf W; Semmler W; van Kaick G; Ho A D; Hunstein W
Magnetic resonance imaging of bone marrow in lymphoproliferative disorders: correlation with bone marrow biopsy.
British journal of haematology 1989;73(1):12-7.
1989: Ho A D; Ganeshaguru K; Knauf W; Dietz G; Trede I; Hoffbrand A V; Hunstein W
Enzyme activities of leukemic cells and biochemical changes induced by deoxycoformycin in vitro--lack of correlation with clinical response.
Leukemia research 1989;13(4):269-78.
1988: Ho A D; Ganeshaguru K; Knauf W U; Dietz G; Trede I; Hunstein W; Hoffbrand A V
Clinical response to deoxycoformycin in chronic lymphoid neoplasms and biochemical changes in circulating malignant cells in vivo.
Blood 1988;72(6):1884-90.
1988: Ho A D; Thaler J; Kuse R; Willemze R; Mandelli F; Lauria F; Zittoun R; Stryckmans P
Deoxycoformycin in therapy of refractory lymphoid neoplasms.
Onkologie 1988;11(1):35-7.
1987: Ho A D; Kuse R; Prümmer O; Porzsolt F; Hunstein W
2'-Deoxycoformycin (Pentostatin) in hairy cell leukemia: response in patients refractory to interferon alpha.
Klinische Wochenschrift 1987;65(20):975-9.
1987: Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho A D; Parwaresch R M; Schmitz N; Papendick U
A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
Leukemia : official journal of the Leukemia Society of America, Leukemia Research Fund, U.K 1987;1(4):337-40.
1987: Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho A D; Parwaresch R M; Schmitz N; Papendick U
[Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy]
Onkologie 1987;10(1):5-10.
1987: Ho A D; Knauf W; Ganeshaguru K; Hunstein W; Hoffbrand A V
Purine degradative enzymes in circulating malignant cells of patients with chronic B cell neoplasia.
Hematological oncology 1987;5(1):9-17.
1987: Ho A D; Martin H; Knauf W; Reichardt P; Trümper L; Hunstein W
Combination of low-dose cytarabine and 13-cis retinoic acid in the treatment of myelodysplastic syndromes.
Leukemia research 1987;11(11):1041-4.
1986: Ho A D; Dietz G; Trede I; Schwartz R; Hoffbrand A V; Hunstein W
Enzymes of purine metabolism in hairy cell leukemia.
Cancer 1986;58(1):96-9.

Sign-in to see more

Sign-in free and Explore the Exciting World of BiomedExperts:

NetworkView

Anthony Ho

Research Profile (preview)

Procedures

Disorders

Anatomy

Concepts & Ideas

Chemicals & Drugs

Network (preview)

Publications

Sign in free and see...

Visualized networks:

GeoTargeted Searches:

Research Profiles:

Geonetwork of Anthony Ho (preview)

All Publications